 | • レポートコード：QY20ST-03717 • 出版社/出版日：QYResearch / 2020年9月15日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、149ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界の臓器移植免疫抑制薬市場について種類別（抗体、抗増殖剤、カルシニューリン阻害剤、mTOR阻害剤、ステロイド）、用途別（骨髄移植、心臓移植、腎臓移植、肝臓移植、肺移植）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・臓器移植免疫抑制薬市場の概要 ・世界の主要地域別臓器移植免疫抑制薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の臓器移植免疫抑制薬市場規模2015-2026：種類別（抗体、抗増殖剤、カルシニューリン阻害剤、mTOR阻害剤、ステロイド） ・世界の臓器移植免疫抑制薬市場規模2015-2026：用途別（骨髄移植、心臓移植、腎臓移植、肝臓移植、肺移植） ・臓器移植免疫抑制薬の北米市場規模2015-2020 ・臓器移植免疫抑制薬のヨーロッパ市場規模2015-2020 ・臓器移植免疫抑制薬の中国市場規模2015-2020 ・臓器移植免疫抑制薬の日本市場規模2015-2020 ・臓器移植免疫抑制薬の東南アジア市場規模2015-2020 ・臓器移植免疫抑制薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・臓器移植免疫抑制薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・臓器移植免疫抑制薬の市場動向・機会・課題 ・調査の結論 |
Solid organ transplantation has been rapidly developed as a therapeutic intervention that is life-saving and greatly contributes to a better quality of life in organ recipients. Organ transplant immunosuppressant drugs can prevent organ rejection post transplantation.
Market Analysis and Insights: Global Organ Transplant Immunosuppressant Drugs Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Organ Transplant Immunosuppressant Drugs market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Organ Transplant Immunosuppressant Drugs industry.
Based on our recent survey, we have several different scenarios about the Organ Transplant Immunosuppressant Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Organ Transplant Immunosuppressant Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Organ Transplant Immunosuppressant Drugs Scope and Market Size
The global Organ Transplant Immunosuppressant Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Organ Transplant Immunosuppressant Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Organ Transplant Immunosuppressant Drugs market is segmented into
Antibodies
Antiproliferative Agents
Calcineurin Inhibitors
mTOR Inhibitors
Steroids
Segment by Application, the Organ Transplant Immunosuppressant Drugs market is segmented into
Bone Marrow Transplant
Heart Transplant
Kidney Transplant
Liver Transplant
Lung Transplant
The Organ Transplant Immunosuppressant Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Organ Transplant Immunosuppressant Drugs market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Organ Transplant Immunosuppressant Drugs Market Share Analysis
Organ Transplant Immunosuppressant Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Organ Transplant Immunosuppressant Drugs business, the date to enter into the Organ Transplant Immunosuppressant Drugs market, Organ Transplant Immunosuppressant Drugs product introduction, recent developments, etc.
The major vendors covered:
F. Hoffmann-La Roche Ltd.
Sanofi
AbbVie, Inc.
Allergan plc.
Astellas Pharma, Inc.
Bristol-Myers Squibb Company
Hoffmann-La Roche Ltd.
GlaxoSmithKline plc
Janssen Pharmaceutical
Novartis AG
Pfizer, Inc.
Veloxis Pharmaceuticals
1 Organ Transplant Immunosuppressant Drugs Market Overview
1.1 Organ Transplant Immunosuppressant Drugs Product Scope
1.2 Organ Transplant Immunosuppressant Drugs Segment by Type
1.2.1 Global Organ Transplant Immunosuppressant Drugs Sales by Type (2020-2026)
1.2.2 Antibodies
1.2.3 Antiproliferative Agents
1.2.4 Calcineurin Inhibitors
1.2.5 mTOR Inhibitors
1.2.6 Steroids
1.3 Organ Transplant Immunosuppressant Drugs Segment by Application
1.3.1 Global Organ Transplant Immunosuppressant Drugs Sales Comparison by Application (2020-2026)
1.3.2 Bone Marrow Transplant
1.3.3 Heart Transplant
1.3.4 Kidney Transplant
1.3.5 Liver Transplant
1.3.6 Lung Transplant
1.4 Organ Transplant Immunosuppressant Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Organ Transplant Immunosuppressant Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Organ Transplant Immunosuppressant Drugs Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Organ Transplant Immunosuppressant Drugs Industry Impact
1.5.1 How the Covid-19 is Affecting the Organ Transplant Immunosuppressant Drugs Industry
1.5.1.1 Organ Transplant Immunosuppressant Drugs Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Organ Transplant Immunosuppressant Drugs Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Organ Transplant Immunosuppressant Drugs Players to Combat Covid-19 Impact
2 Organ Transplant Immunosuppressant Drugs Estimate and Forecast by Region
2.1 Global Organ Transplant Immunosuppressant Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Organ Transplant Immunosuppressant Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Organ Transplant Immunosuppressant Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Organ Transplant Immunosuppressant Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Organ Transplant Immunosuppressant Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Organ Transplant Immunosuppressant Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Organ Transplant Immunosuppressant Drugs Estimates and Projections (2015-2026)
2.4.3 China Organ Transplant Immunosuppressant Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Organ Transplant Immunosuppressant Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Organ Transplant Immunosuppressant Drugs Estimates and Projections (2015-2026)
2.4.6 India Organ Transplant Immunosuppressant Drugs Estimates and Projections (2015-2026)
3 Global Organ Transplant Immunosuppressant Drugs Competition Landscape by Players
3.1 Global Top Organ Transplant Immunosuppressant Drugs Players by Sales (2015-2020)
3.2 Global Top Organ Transplant Immunosuppressant Drugs Players by Revenue (2015-2020)
3.3 Global Organ Transplant Immunosuppressant Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Organ Transplant Immunosuppressant Drugs as of 2019)
3.4 Global Organ Transplant Immunosuppressant Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Organ Transplant Immunosuppressant Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Organ Transplant Immunosuppressant Drugs Players (Opinion Leaders)
4 Global Organ Transplant Immunosuppressant Drugs Market Size by Type
4.1 Global Organ Transplant Immunosuppressant Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Organ Transplant Immunosuppressant Drugs Price by Type (2014-2020)
4.2 Global Organ Transplant Immunosuppressant Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Organ Transplant Immunosuppressant Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Organ Transplant Immunosuppressant Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Organ Transplant Immunosuppressant Drugs Price Forecast by Type (2021-2026)
5 Global Organ Transplant Immunosuppressant Drugs Market Size by Application
5.1 Global Organ Transplant Immunosuppressant Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Organ Transplant Immunosuppressant Drugs Price by Application (2015-2020)
5.2 Global Organ Transplant Immunosuppressant Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Organ Transplant Immunosuppressant Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Organ Transplant Immunosuppressant Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Organ Transplant Immunosuppressant Drugs Price Forecast by Application (2021-2026)
3 North America Organ Transplant Immunosuppressant Drugs Market Facts & Figures
3.2 North America Organ Transplant Immunosuppressant Drugs Sales Market Share by Company (2015-2020)
3.3 North America Organ Transplant Immunosuppressant Drugs Sales Market Share by Type (2015-2020)
3.4 North America Organ Transplant Immunosuppressant Drugs Sales Market Share by Application (2015-2020)
4 Europe Organ Transplant Immunosuppressant Drugs Market Facts & Figures
4.2 Europe Organ Transplant Immunosuppressant Drugs Sales Market Share by Company (2015-2020)
4.3 Europe Organ Transplant Immunosuppressant Drugs Sales Market Share by Type (2015-2020)
4.4 Europe Organ Transplant Immunosuppressant Drugs Sales Market Share by Application (2015-2020)
5 China Organ Transplant Immunosuppressant Drugs Market Facts & Figures
5.2 China Organ Transplant Immunosuppressant Drugs Sales Market Share by Company (2015-2020)
5.3 China Organ Transplant Immunosuppressant Drugs Sales Market Share by Type (2015-2020)
5.4 China Organ Transplant Immunosuppressant Drugs Sales Market Share by Application (2015-2020)
6 Japan Organ Transplant Immunosuppressant Drugs Market Facts & Figures
6.2 Japan Organ Transplant Immunosuppressant Drugs Sales Market Share by Company (2015-2020)
6.3 Japan Organ Transplant Immunosuppressant Drugs Sales Market Share by Type (2015-2020)
6.4 Japan Organ Transplant Immunosuppressant Drugs Sales Market Share by Application (2015-2020)
7 Southeast Asia Organ Transplant Immunosuppressant Drugs Market Facts & Figures
7.2 Southeast Asia Organ Transplant Immunosuppressant Drugs Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Organ Transplant Immunosuppressant Drugs Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Organ Transplant Immunosuppressant Drugs Sales Market Share by Application (2015-2020)
8 India Organ Transplant Immunosuppressant Drugs Market Facts & Figures
8.2 India Organ Transplant Immunosuppressant Drugs Sales Market Share by Company (2015-2020)
8.3 India Organ Transplant Immunosuppressant Drugs Sales Market Share by Type (2015-2020)
8.4 India Organ Transplant Immunosuppressant Drugs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Organ Transplant Immunosuppressant Drugs Business
12.1 F. Hoffmann-La Roche Ltd.
12.1.1 F. Hoffmann-La Roche Ltd. Organ Transplant Immunosuppressant Drugs Corporation Information
12.1.2 F. Hoffmann-La Roche Ltd. Organ Transplant Immunosuppressant Drugs Business Overview and Total Revenue
12.1.3 F. Hoffmann-La Roche Ltd. Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 F. Hoffmann-La Roche Ltd. Organ Transplant Immunosuppressant Drugs Products Offered
12.1.5 F. Hoffmann-La Roche Ltd. Recent Development
12.2 Sanofi
12.2.1 Sanofi Organ Transplant Immunosuppressant Drugs Corporation Information
12.2.2 Sanofi Organ Transplant Immunosuppressant Drugs Business Overview and Total Revenue
12.2.3 Sanofi Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Sanofi Organ Transplant Immunosuppressant Drugs Products Offered
12.2.5 Sanofi Recent Development
12.3 AbbVie, Inc.
12.3.1 AbbVie, Inc. Organ Transplant Immunosuppressant Drugs Corporation Information
12.3.2 AbbVie, Inc. Organ Transplant Immunosuppressant Drugs Business Overview and Total Revenue
12.3.3 AbbVie, Inc. Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 AbbVie, Inc. Organ Transplant Immunosuppressant Drugs Products Offered
12.3.5 AbbVie, Inc. Recent Development
12.4 Allergan plc.
12.4.1 Allergan plc. Organ Transplant Immunosuppressant Drugs Corporation Information
12.4.2 Allergan plc. Organ Transplant Immunosuppressant Drugs Business Overview and Total Revenue
12.4.3 Allergan plc. Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Allergan plc. Organ Transplant Immunosuppressant Drugs Products Offered
12.4.5 Allergan plc. Recent Development
12.5 Astellas Pharma, Inc.
12.5.1 Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Corporation Information
12.5.2 Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Business Overview and Total Revenue
12.5.3 Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Products Offered
12.5.5 Astellas Pharma, Inc. Recent Development
12.6 Bristol-Myers Squibb Company
12.6.1 Bristol-Myers Squibb Company Organ Transplant Immunosuppressant Drugs Corporation Information
12.6.2 Bristol-Myers Squibb Company Organ Transplant Immunosuppressant Drugs Business Overview and Total Revenue
12.6.3 Bristol-Myers Squibb Company Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Bristol-Myers Squibb Company Organ Transplant Immunosuppressant Drugs Products Offered
12.6.5 Bristol-Myers Squibb Company Recent Development
12.7 Hoffmann-La Roche Ltd.
12.7.1 Hoffmann-La Roche Ltd. Organ Transplant Immunosuppressant Drugs Corporation Information
12.7.2 Hoffmann-La Roche Ltd. Organ Transplant Immunosuppressant Drugs Business Overview and Total Revenue
12.7.3 Hoffmann-La Roche Ltd. Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Hoffmann-La Roche Ltd. Organ Transplant Immunosuppressant Drugs Products Offered
12.7.5 Hoffmann-La Roche Ltd. Recent Development
12.8 GlaxoSmithKline plc
12.8.1 GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Corporation Information
12.8.2 GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Business Overview and Total Revenue
12.8.3 GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Products Offered
12.8.5 GlaxoSmithKline plc Recent Development
12.9 Janssen Pharmaceutical
12.9.1 Janssen Pharmaceutical Organ Transplant Immunosuppressant Drugs Corporation Information
12.9.2 Janssen Pharmaceutical Organ Transplant Immunosuppressant Drugs Business Overview and Total Revenue
12.9.3 Janssen Pharmaceutical Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Janssen Pharmaceutical Organ Transplant Immunosuppressant Drugs Products Offered
12.9.5 Janssen Pharmaceutical Recent Development
12.10 Novartis AG
12.10.1 Novartis AG Organ Transplant Immunosuppressant Drugs Corporation Information
12.10.2 Novartis AG Organ Transplant Immunosuppressant Drugs Business Overview and Total Revenue
12.10.3 Novartis AG Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Novartis AG Organ Transplant Immunosuppressant Drugs Products Offered
12.10.5 Novartis AG Recent Development
12.11 Pfizer, Inc.
12.11.1 Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Corporation Information
12.11.2 Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Business Overview and Total Revenue
12.11.3 Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Products Offered
12.11.5 Pfizer, Inc. Recent Development
12.12 Veloxis Pharmaceuticals
12.12.1 Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Corporation Information
12.12.2 Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Business Overview and Total Revenue
12.12.3 Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Products Offered
12.12.5 Veloxis Pharmaceuticals Recent Development
13 Organ Transplant Immunosuppressant Drugs Manufacturing Cost Analysis
13.1 Organ Transplant Immunosuppressant Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Organ Transplant Immunosuppressant Drugs
13.4 Organ Transplant Immunosuppressant Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Organ Transplant Immunosuppressant Drugs Distributors List
14.3 Organ Transplant Immunosuppressant Drugs Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Organ Transplant Immunosuppressant Drugs Sales (K Doses) Growth Rate by Type (2020-2026)
Table 2. Global Organ Transplant Immunosuppressant Drugs Sales (K Doses) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Organ Transplant Immunosuppressant Drugs Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Organ Transplant Immunosuppressant Drugs Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Organ Transplant Immunosuppressant Drugs Players to Combat Covid-19 Impact
Table 8. Global Market Organ Transplant Immunosuppressant Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Region (2015-2020)
Table 10. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Region (2015-2020)
Table 11. Global Organ Transplant Immunosuppressant Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Organ Transplant Immunosuppressant Drugs Revenue Share by Region (2015-2020)
Table 13. Global Organ Transplant Immunosuppressant Drugs Sales (K Doses) Forecast by Region (2021-2026)
Table 14. Global Organ Transplant Immunosuppressant Drugs Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Organ Transplant Immunosuppressant Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Organ Transplant Immunosuppressant Drugs Revenue Share Forecast by Region (2021-2026)
Table 17. Global Organ Transplant Immunosuppressant Drugs (K Doses) of Key Companies (2015-2020)
Table 18. Global Organ Transplant Immunosuppressant Drugs Sales Share by Company (2015-2020)
Table 19. Global Organ Transplant Immunosuppressant Drugs Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Organ Transplant Immunosuppressant Drugs Revenue Share by Company (2015-2020)
Table 21. Global Organ Transplant Immunosuppressant Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Organ Transplant Immunosuppressant Drugs as of 2019)
Table 22. Global Organ Transplant Immunosuppressant Drugs Average Price (USD/ Dose) of Key Company (2015-2020)
Table 23. Manufacturers Organ Transplant Immunosuppressant Drugs Manufacturing Sites and Area Served
Table 24. Manufacturers Organ Transplant Immunosuppressant Drugs Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Organ Transplant Immunosuppressant Drugs Players
Table 27. Global Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Type (2015-2020)
Table 28. Global Organ Transplant Immunosuppressant Drugs Sales Share by Type (2015-2020)
Table 29. Global Organ Transplant Immunosuppressant Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Organ Transplant Immunosuppressant Drugs Price (K Doses) by Type (2015-2020)
Table 31. Global Organ Transplant Immunosuppressant Drugs Sales Share by Type (2021-2026)
Table 32. Global Organ Transplant Immunosuppressant Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Organ Transplant Immunosuppressant Drugs Revenue Share by Type (2021-2026)
Table 34. Global Organ Transplant Immunosuppressant Drugs Price (K Doses) by Type (2021-2026)
Table 35. Global Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Application (2015-2020)
Table 36. Global Organ Transplant Immunosuppressant Drugs Sales Share by Application (2015-2020)
Table 37. Global Organ Transplant Immunosuppressant Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Organ Transplant Immunosuppressant Drugs Price (K Doses) by Application (2015-2020)
Table 39. Global Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Application (2021-2026)
Table 40. Global Organ Transplant Immunosuppressant Drugs Sales Share by Application (2021-2026)
Table 41. Global Organ Transplant Immunosuppressant Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Organ Transplant Immunosuppressant Drugs Revenue Share by Application (2021-2026)
Table 43. Global Organ Transplant Immunosuppressant Drugs Price (K Doses) by Application (2021-2026)
Table 44. United States Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Company (2015-2020)
Table 45. United States Organ Transplant Immunosuppressant Drugs Sales Market Share by Company (2015-2020)
Table 46. United States Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Type (2015-2020)
Table 47. United States Organ Transplant Immunosuppressant Drugs Sales Market Share by Type (2015-2020)
Table 48. United States Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Application (2015-2020)
Table 49. United States Organ Transplant Immunosuppressant Drugs Sales Market Share by Application (2015-2020)
Table 50. Europe Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Company (2015-2020)
Table 51. Europe Organ Transplant Immunosuppressant Drugs Sales Market Share by Company (2015-2020)
Table 52. Europe Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Type (2015-2020)
Table 53. Europe Organ Transplant Immunosuppressant Drugs Sales Market Share by Type (2015-2020)
Table 54. Europe Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Application (2015-2020)
Table 55. Europe Organ Transplant Immunosuppressant Drugs Sales Market Share by Type (2015-2020)
Table 56. China Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Company (2015-2020)
Table 57. China Organ Transplant Immunosuppressant Drugs Sales Market Share by Company (2015-2020)
Table 58. China Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Type (2015-2020)
Table 59. China Organ Transplant Immunosuppressant Drugs Sales Market Share by Type (2015-2020)
Table 60. China Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Application (2015-2020)
Table 61. China Organ Transplant Immunosuppressant Drugs Sales Market Share by Application (2015-2020)
Table 62. Japan Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Company (2015-2020)
Table 63. Japan Organ Transplant Immunosuppressant Drugs Sales Market Share by Company (2015-2020)
Table 64. Japan Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Type (2015-2020)
Table 65. Japan Organ Transplant Immunosuppressant Drugs Sales Market Share by Type (2015-2020)
Table 66. Japan Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Application (2015-2020)
Table 67. Japan Organ Transplant Immunosuppressant Drugs Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Company (2015-2020)
Table 69. Southeast Asia Organ Transplant Immunosuppressant Drugs Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Type (2015-2020)
Table 71. Southeast Asia Organ Transplant Immunosuppressant Drugs Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Type (2015-2020)
Table 73. Southeast Asia Organ Transplant Immunosuppressant Drugs Sales Market Share by Application (2015-2020)
Table 74. India Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Company (2015-2020)
Table 75. India Organ Transplant Immunosuppressant Drugs Sales Market Share by Company (2015-2020)
Table 76. India Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Type (2015-2020)
Table 77. India Organ Transplant Immunosuppressant Drugs Sales Market Share by Type (2015-2020)
Table 78. India Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Application (2015-2020)
Table 79. India Organ Transplant Immunosuppressant Drugs Sales Market Share by Application (2015-2020)
Table 80. F. Hoffmann-La Roche Ltd. Corporation Information
Table 81. F. Hoffmann-La Roche Ltd. Description and Business Overview
Table 82. F. Hoffmann-La Roche Ltd. Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (Million USD), Price (USD/ Dose) and Gross Margin (2015-2020)
Table 83. F. Hoffmann-La Roche Ltd. Organ Transplant Immunosuppressant Drugs Product
Table 84. F. Hoffmann-La Roche Ltd. Recent Development
Table 85. Sanofi Corporation Information
Table 86. Sanofi Description and Business Overview
Table 87. Sanofi Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (Million USD), Price (USD/ Dose) and Gross Margin (2015-2020)
Table 88. Sanofi Organ Transplant Immunosuppressant Drugs Product
Table 89. Sanofi Recent Development
Table 90. AbbVie, Inc. Corporation Information
Table 91. AbbVie, Inc. Description and Business Overview
Table 92. AbbVie, Inc. Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (Million USD), Price (USD/ Dose) and Gross Margin (2015-2020)
Table 93. AbbVie, Inc. Organ Transplant Immunosuppressant Drugs Product
Table 94. AbbVie, Inc. Recent Development
Table 95. Allergan plc. Corporation Information
Table 96. Allergan plc. Description and Business Overview
Table 97. Allergan plc. Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (Million USD), Price (USD/ Dose) and Gross Margin (2015-2020)
Table 98. Allergan plc. Organ Transplant Immunosuppressant Drugs Product
Table 99. Allergan plc. Recent Development
Table 100. Astellas Pharma, Inc. Corporation Information
Table 101. Astellas Pharma, Inc. Description and Business Overview
Table 102. Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (Million USD), Price (USD/ Dose) and Gross Margin (2015-2020)
Table 103. Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Product
Table 104. Astellas Pharma, Inc. Recent Development
Table 105. Bristol-Myers Squibb Company Corporation Information
Table 106. Bristol-Myers Squibb Company Description and Business Overview
Table 107. Bristol-Myers Squibb Company Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (Million USD), Price (USD/ Dose) and Gross Margin (2015-2020)
Table 108. Bristol-Myers Squibb Company Organ Transplant Immunosuppressant Drugs Product
Table 109. Bristol-Myers Squibb Company Recent Development
Table 110. Hoffmann-La Roche Ltd. Corporation Information
Table 111. Hoffmann-La Roche Ltd. Description and Business Overview
Table 112. Hoffmann-La Roche Ltd. Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (Million USD), Price (USD/ Dose) and Gross Margin (2015-2020)
Table 113. Hoffmann-La Roche Ltd. Organ Transplant Immunosuppressant Drugs Product
Table 114. Hoffmann-La Roche Ltd. Recent Development
Table 115. GlaxoSmithKline plc Corporation Information
Table 116. GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (Million USD), Price (USD/ Dose) and Gross Margin (2015-2020)
Table 117. GlaxoSmithKline plc Description and Business Overview
Table 118. GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Product
Table 119. GlaxoSmithKline plc Recent Development
Table 120. Janssen Pharmaceutical Corporation Information
Table 121. Janssen Pharmaceutical Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (Million USD), Price (USD/ Dose) and Gross Margin (2015-2020)
Table 122. Janssen Pharmaceutical Description and Business Overview
Table 123. Janssen Pharmaceutical Organ Transplant Immunosuppressant Drugs Product
Table 124. Janssen Pharmaceutical Recent Development
Table 125. Novartis AG Corporation Information
Table 126. Novartis AG Description and Business Overview
Table 127. Novartis AG Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (Million USD), Price (USD/ Dose) and Gross Margin (2015-2020)
Table 128. Novartis AG Organ Transplant Immunosuppressant Drugs Product
Table 129. Novartis AG Recent Development
Table 130. Pfizer, Inc. Corporation Information
Table 131. Pfizer, Inc. Description and Business Overview
Table 132. Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (Million USD), Price (USD/ Dose) and Gross Margin (2015-2020)
Table 133. Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Product
Table 134. Pfizer, Inc. Recent Development
Table . Veloxis Pharmaceuticals Corporation Information
Table . Veloxis Pharmaceuticals Description and Business Overview
Table . Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (Million USD), Price (USD/ Dose) and Gross Margin (2015-2020)
Table . Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Product
Table . Veloxis Pharmaceuticals Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. Organ Transplant Immunosuppressant Drugs Distributors List
Table 143. Organ Transplant Immunosuppressant Drugs Customers List
Table 144. Market Key Trends
Table 145. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 146. Key Challenges
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Organ Transplant Immunosuppressant Drugs Product Picture
Figure 2. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Organ Transplant Immunosuppressant Drugs Market Share by Application in 2020 & 2026
Figure 6. Bone Marrow Transplant Examples
Figure 7. Heart Transplant Examples
Figure 8. Kidney Transplant Examples
Figure 9. Liver Transplant Examples
Figure 10. Lung Transplant Examples
Figure 11. Global Organ Transplant Immunosuppressant Drugs Sales (K Doses) Growth Rate (2015-2026)
Figure 12. Global Organ Transplant Immunosuppressant Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 13. Global Organ Transplant Immunosuppressant Drugs Price Trends Growth Rate (2015-2026) (USD/ Dose)
Figure 14. Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 15. Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 16. United States Organ Transplant Immunosuppressant Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. United States Organ Transplant Immunosuppressant Drugs Sales (K Doses) Growth Rate (2015-2026)
Figure 18. Europe Organ Transplant Immunosuppressant Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. Europe Organ Transplant Immunosuppressant Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 20. China Organ Transplant Immunosuppressant Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. China Organ Transplant Immunosuppressant Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 22. Japan Organ Transplant Immunosuppressant Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Japan Organ Transplant Immunosuppressant Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Organ Transplant Immunosuppressant Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia Organ Transplant Immunosuppressant Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 26. India Organ Transplant Immunosuppressant Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. India Organ Transplant Immunosuppressant Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 28. Global 5 Largest Organ Transplant Immunosuppressant Drugs Players Market Share by Revenue in Organ Transplant Immunosuppressant Drugs 2015 & 2019
Figure 29. Organ Transplant Immunosuppressant Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 30. Global Organ Transplant Immunosuppressant Drugs Revenue Share by Type (2015-2020)
Figure 31. Global Organ Transplant Immunosuppressant Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 32. Global Organ Transplant Immunosuppressant Drugs Revenue Share by Application (2015-2020)
Figure 33. Global Organ Transplant Immunosuppressant Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 34. United States Organ Transplant Immunosuppressant Drugs Sales Market Share by Type in 2019
Figure 35. United States Organ Transplant Immunosuppressant Drugs Sales Market Share by Type in 2019
Figure 36. Europe Organ Transplant Immunosuppressant Drugs Sales Market Share by Company in 2019
Figure 37. Europe Organ Transplant Immunosuppressant Drugs Sales Market Share by Type in 2019
Figure 38. Europe Organ Transplant Immunosuppressant Drugs Sales Market Share by Application in 2019
Figure 39. China Organ Transplant Immunosuppressant Drugs Sales Market Share by Company in 2019
Figure 40. China Organ Transplant Immunosuppressant Drugs Sales Market Share by Type in 2019
Figure 41. China Organ Transplant Immunosuppressant Drugs Sales Market Share by Application in 2019
Figure 42. Japan Organ Transplant Immunosuppressant Drugs Sales Market Share by Company in 2019
Figure 43. Japan Organ Transplant Immunosuppressant Drugs Sales Market Share by Type in 2019
Figure 44. Japan Organ Transplant Immunosuppressant Drugs Sales Market Share by Application in 2019
Figure 45. Southeast Asia Organ Transplant Immunosuppressant Drugs Sales Market Share by Company in 2019
Figure 46. Southeast Asia Organ Transplant Immunosuppressant Drugs Sales Market Share by Type in 2019
Figure 47. Southeast Asia Organ Transplant Immunosuppressant Drugs Sales Market Share by Application in 2019
Figure 48. India Organ Transplant Immunosuppressant Drugs Sales Market Share by Company in 2019
Figure 49. India Organ Transplant Immunosuppressant Drugs Sales Market Share by Type in 2019
Figure 50. India Organ Transplant Immunosuppressant Drugs Sales Market Share by Application in 2019
Figure 51. F. Hoffmann-La Roche Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. AbbVie, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Allergan plc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Astellas Pharma, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Bristol-Myers Squibb Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Hoffmann-La Roche Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. GlaxoSmithKline plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Janssen Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Pfizer, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Veloxis Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Key Raw Materials Price Trend
Figure 64. Manufacturing Cost Structure of Organ Transplant Immunosuppressant Drugs
Figure 65. Manufacturing Process Analysis of Organ Transplant Immunosuppressant Drugs
Figure 66. Organ Transplant Immunosuppressant Drugs Industrial Chain Analysis
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
Figure 69. Porter's Five Forces Analysis
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
臓器移植免疫抑制薬の世界市場レポート2020 Solid organ transplantation has been rapidly developed as a therapeutic intervention that is life-saving and greatly contributes to a better quality of life in organ recipients. Organ transplant immunosuppressant drugs can prevent organ rejection post transplantation. Market Analysis and Insights: G…- 臓器移植免疫抑制薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Organ Transplantation Immunosuppressive Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The …
- 臓器移植診断の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Organ Transplant Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Organ Transplant…
- 臓器移植用拒絶反応防止薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Organ Transplant Anti-rejection Medications market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The O…
- オルガンオンチップ（OOC）の世界市場レポート2020 A recently published report by QY Research titled Global Organ-On-Chip (OOC) Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurat…